(2S,3S,4R,5R,6R)-6-(4-amino-2-oxopyrimidin-1(2H)-yl)-4,5-dihydroxy-3-((S)-3-hydroxy-2-(2-(methylamino)acetamido)propanamido)-tetrahydro-2H-pyran-2-carboxamide

ID: ALA458302

Chembl Id: CHEMBL458302

Cas Number: 156410-09-2

PubChem CID: 44588235

Max Phase: Preclinical

Molecular Formula: C16H25N7O8

Molecular Weight: 443.42

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Ningnamycin | Ningnanmycin | ningnanmycin|Ningnamycin|156410-09-2|beta-D-Glucopyranuronamide, 1-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,4-dideoxy-4-[(N-methylglycyl-L-seryl)amino]-|CHEMBL458302|SCHEMBL17193751|DTXSID601020469|.beta.-D-Glucopyranuronamide, 1-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,4-dideoxy-4-[(N-methylglycyl-L-seryl)amino]-

Canonical SMILES:  CNCC(=O)N[C@@H](CO)C(=O)N[C@H]1[C@H](O)[C@@H](O)[C@H](n2ccc(N)nc2=O)O[C@@H]1C(N)=O

Standard InChI:  InChI=1S/C16H25N7O8/c1-19-4-8(25)20-6(5-24)14(29)22-9-10(26)11(27)15(31-12(9)13(18)28)23-3-2-7(17)21-16(23)30/h2-3,6,9-12,15,19,24,26-27H,4-5H2,1H3,(H2,18,28)(H,20,25)(H,22,29)(H2,17,21,30)/t6-,9-,10-,11+,12-,15+/m0/s1

Standard InChI Key:  AMNAZJFEONUVTD-KEWDHRJRSA-N

Alternative Forms

  1. Parent:

    ALA458302

    NINGNANMYCIN

Associated Targets(non-human)

Tobacco mosaic virus (2972 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 443.42Molecular Weight (Monoisotopic): 443.1765AlogP: -5.89#Rotatable Bonds: 8
Polar Surface Area: 244.15Molecular Species: BASEHBA: 12HBD: 8
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 10#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.58CX Basic pKa: 8.50CX LogP: -6.28CX LogD: -7.41
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.19Np Likeness Score: 0.80

References

1. Chen Z, Wang X, Song B, Wang H, Bhadury PS, Yan K, Zhang H, Yang S, Jin L, Hu D, Xue W, Zeng S, Wang J..  (2008)  Synthesis and antiviral activities of novel chiral cyanoacrylate derivatives with (E) configuration.,  16  (6): [PMID:18178446] [10.1016/j.bmc.2007.12.035]
2. Ouyang G, Chen Z, Cai XJ, Song BA, Bhadury PS, Yang S, Jin LH, Xue W, Hu DY, Zeng S..  (2008)  Synthesis and antiviral activity of novel pyrazole derivatives containing oxime esters group.,  16  (22): [PMID:18945621] [10.1016/j.bmc.2008.09.070]
3. Hu QF, Zhou B, Gao XM, Yang LY, Shu LD, Shen Y, Li GP, Che CT, Yang GY..  (2012)  Antiviral chromones from the stem of Cassia siamea.,  75  (11): [PMID:23078294] [10.1021/np300395m]
4. Wang K, Su B, Wang Z, Wu M, Li Z, Hu Y, Fan Z, Mi N, Wang Q..  (2010)  Synthesis and antiviral activities of phenanthroindolizidine alkaloids and their derivatives.,  58  (5): [PMID:20000413] [10.1021/jf902543r]
5. Hu DY, Wan QQ, Yang S, Song BA, Bhadury PS, Jin LH, Yan K, Liu F, Chen Z, Xue W..  (2008)  Synthesis and antiviral activities of amide derivatives containing the alpha-aminophosphonate moiety.,  56  (3): [PMID:18183949] [10.1021/jf072394k]
6. Long N, Cai XJ, Song BA, Yang S, Chen Z, Bhadury PS, Hu DY, Jin LH, Xue W..  (2008)  Synthesis and antiviral activities of cyanoacrylate derivatives containing an alpha-aminophosphonate moiety.,  56  (13): [PMID:18547045] [10.1021/jf800405m]
7. Yan XH, Chen J, Di YT, Fang X, Dong JH, Sang P, Wang YH, He HP, Zhang ZK, Hao XJ..  (2010)  Anti-tobacco mosaic virus (TMV) Quassinoids from Brucea javanica (L.) Merr.,  58  (3): [PMID:20050684] [10.1021/jf903434h]
8. Ouyang G, Cai XJ, Chen Z, Song BA, Bhadury PS, Yang S, Jin LH, Xue W, Hu DY, Zeng S..  (2008)  Synthesis and antiviral activities of pyrazole derivatives containing an oxime moiety.,  56  (21): [PMID:18939848] [10.1021/jf802489e]
9. Ge YH, Liu KX, Zhang JX, Mu SZ, Hao XJ..  (2012)  The limonoids and their antitobacco mosaic virus (TMV) activities from Munronia unifoliolata Oliv.,  60  (17): [PMID:22500574] [10.1021/jf205362d]
10. Chen MH, Chen Z, Song BA, Bhadury PS, Yang S, Cai XJ, Hu DY, Xue W, Zeng S..  (2009)  Synthesis and antiviral activities of chiral thiourea derivatives containing an alpha-aminophosphonate moiety.,  57  (4): [PMID:19199594] [10.1021/jf803215t]
11. Wang Z, Wang L, Ma S, Liu Y, Wang L, Wang Q..  (2012)  Design, synthesis, antiviral activity, and SARs of 14-aminophenanthroindolizidines.,  60  (23): [PMID:22662864] [10.1021/jf3013376]
12. Chen J, Yan XH, Dong JH, Sang P, Fang X, Di YT, Zhang ZK, Hao XJ..  (2009)  Tobacco mosaic virus (TMV) inhibitors from Picrasma quassioides Benn.,  57  (15): [PMID:19586051] [10.1021/jf901632j]
13. Wang K, Hu Y, Liu Y, Mi N, Fan Z, Liu Y, Wang Q..  (2010)  Design, synthesis, and antiviral evaluation of phenanthrene-based tylophorine derivatives as potential antiviral agents.,  58  (23): [PMID:21058739] [10.1021/jf103440s]
14. Yang JQ, Song BA, Bhadury PS, Chen Z, Yang S, Cai XJ, Hu DY, Xue W..  (2010)  Synthesis and antiviral bioactivities of 2-cyano-3-substituted-amino(phenyl) methylphosphonylacrylates (acrylamides) containing alkoxyethyl moieties.,  58  (5): [PMID:20000408] [10.1021/jf902861m]
15. Wang Z, Wei P, Wang L, Wang Q..  (2012)  Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues.,  60  (41): [PMID:23035814] [10.1021/jf303550a]
16. Song B, Zhang H, Wang H, Yang S, Jin L, Hu D, Pang L, Xue W..  (2005)  Synthesis and antiviral activity of novel chiral cyanoacrylate derivatives.,  53  (20): [PMID:16190646] [10.1021/jf051050w]
17. Wu M, Han G, Wang Z, Liu Y, Wang Q..  (2013)  Synthesis and antiviral activities of antofine analogues with different C-6 substituent groups.,  61  (5): [PMID:23320928] [10.1021/jf304905k]
18. Hu QF, Zhou B, Huang JM, Gao XM, Shu LD, Yang GY, Che CT..  (2013)  Antiviral phenolic compounds from Arundina gramnifolia.,  76  (2): [PMID:23368966] [10.1021/np300727f]
19. Yan Y, Zhang JX, Huang T, Mao XY, Gu W, He HP, Di YT, Li SL, Chen DZ, Zhang Y, Hao XJ..  (2015)  Bioactive Limonoid Constituents of Munronia henryi.,  78  (4): [PMID:25798528] [10.1021/np501057f]
20. Wu RJ, Zhou KX, Yang H, Song GQ, Li YH, Fu JX, Zhang X, Yu SJ, Wang LZ, Xiong LX, Niu CW, Song FH, Yang H, Wang JG..  (2019)  Chemical synthesis, crystal structure, versatile evaluation of their biological activities and molecular simulations of novel pyrithiobac derivatives.,  167  [PMID:30784880] [10.1016/j.ejmech.2019.02.002]
21. Brandão P, Marques C, Burke AJ, Pineiro M..  (2021)  The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules.,  211  [PMID:33421712] [10.1016/j.ejmech.2020.113102]
22. Wang J, Gong F, Liang T, Xie Z, Yang Y, Cao C, Gao J, Lu T, Chen X..  (2021)  A review of synthetic bioactive tetrahydro-β-carbolines: A medicinal chemistry perspective.,  225  [PMID:34479038] [10.1016/j.ejmech.2021.113815]

Source